cFLIPL acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-κB-activating complexes
Cell Reports · 2023-12 · 42 (12) · 113476
DOI: 10.1016/j.celrep.2023.113476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-12. Verfasst von Pavel Davidovich und 4 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Cell Biology Laboratory, Department of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland. Hauptthemen laut MEDLINE: NF-kappa B, Apoptosis Regulatory Proteins. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Research Council, Irish Research Council.
Abstract (Originalsprache)
TRAIL and FasL are potent inducers of apoptosis but can also promote inflammation through assembly of cytoplasmic caspase-8/FADD/RIPK1 (FADDosome) complexes, wherein caspase-8 acts as a scaffold to drive FADD/RIPK1-mediated nuclear factor κB (NF-κB) activation. cFLIP is also recruited to FADDosomes and restricts caspase-8 activity and apoptosis, but whether cFLIP also regulates death receptor-initiated inflammation is unclear. Here, we show that silencing or deletion of cFLIP leads to robustly enhanced Fas-, TRAIL-, or TLR3-induced inflammatory cytokine production, which can be uncoupled from the effects of cFLIP on caspase-8 activation and apoptosis. Mechanistically, cFLIPL suppresses Fas- or TRAIL-initiated NF-κB activation through inhibiting the assembly of caspase-8/FADD/RIPK1 FADDosome complexes, due to the low affinity of cFLIPL for FADD. Consequently, increased cFLIPL occupancy of FADDosomes diminishes recruitment of FADD/RIPK1 to caspase-8, thereby suppressing NF-κB activation and inflammatory cytokine production downstream. Thus, cFLIP acts as a dual suppressor of apoptosis and inflammation via distinct modes of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Cell Biology Laboratory, Department of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland.
- Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK.
- Molecular Cell Biology Laboratory, Department of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland. Electronic address: martinsj@tcd.ie.
Förderung
- European Research Council
- Irish Research Council
Zitieren
APA
Davidovich, P., Higgins, C. A., Najda, Z., Longley, D. B., & Martin, S. J. (2023). cFLIPL acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-κB-activating complexes. Cell Reports, 42(12), 113476. https://doi.org/10.1016/j.celrep.2023.113476
Vancouver
Davidovich P, Higgins CA, Najda Z, Longley DB, Martin SJ. cFLIPL acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-κB-activating complexes. Cell Reports. 2023;42(12):113476. doi:10.1016/j.celrep.2023.113476
BibTeX
@article{Davidovich2023,
author = {Davidovich, Pavel and Higgins, Catherine A and Najda, Zaneta and Longley, Daniel B and Martin, Seamus J},
title = {cFLIPL acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-κB-activating complexes},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {12},
pages = {113476},
doi = {10.1016/j.celrep.2023.113476}
}
EUVIMED